Literature DB >> 4440505

Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.

L Nyberg, K E Andersson, A Bertler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4440505

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN: 0001-6675


× No keyword cloud information.
  8 in total

1.  Absorption of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

2.  Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

3.  Fasting and postprandial absorption of digoxin from a microencapsulated formulation.

Authors:  B Bergdahl; C Bogentoft; U E Jonsson; J O Magnusson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics and dosagae of digoxin in neonates and infants.

Authors:  L Nyberg; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

5.  Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization.

Authors:  K E Andersson; L Nyberg; H Dencker; J Göthlin
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

Review 6.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.

Authors:  G G Belz; H Schreiter; G K Wolf
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

8.  Absorption of digoxin from a new microencapsulated formulation.

Authors:  B Bergdahl; C Bogentoft; U E Jonsson; J O Magnusson
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.